Literature DB >> 18040786

Does inflammation in an autoimmune disease differ from inflammation in neurodegenerative diseases? Possible implications for therapy.

Michal Schwartz1, Oleg Butovsky, Jonathan Kipnis.   

Abstract

Accumulating evidence suggests that neurodegenerative diseases of the central nervous system (CNS) are associated with a local inflammatory response. CNS autoimmune diseases are also associated with inflammation. Does this mean that all neurodegenerative diseases are autoimmune in nature? Does it imply that autoimmune and neurodegenerative diseases are both eligible for the same therapy? What distinguishes between the two types of disease? Do they differ both in etiology and in pathology, or do they have different etiologies but similar pathology and progression? In this minireview we offer a new view of the inflammatory differences between neurodegenerative and autoimmune diseases in the CNS and discuss the implications for therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 18040786     DOI: 10.1007/s11481-005-9010-2

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   7.285


  83 in total

1.  Early activation of microglia as antigen-presenting cells correlates with T cell-mediated protection and repair of the injured central nervous system.

Authors:  Iftach Shaked; Ziv Porat; Roman Gersner; Jonathan Kipnis; Michal Schwartz
Journal:  J Neuroimmunol       Date:  2004-01       Impact factor: 3.478

Review 2.  Microglial phenotype: is the commitment reversible?

Authors:  Michal Schwartz; Oleg Butovsky; Wolfgang Brück; Uwe-Karsten Hanisch
Journal:  Trends Neurosci       Date:  2006-01-06       Impact factor: 13.837

Review 3.  Immune response of neonates elicited by somatic transgene vaccination with naked DNA.

Authors:  A Bot; S Antohi; C Bona
Journal:  Front Biosci       Date:  1997-05-01

Review 4.  Specific vaccines against autoimmune diseases.

Authors:  M Sela
Journal:  C R Acad Sci III       Date:  1999-11

5.  Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma.

Authors:  H Schori; J Kipnis; E Yoles; E WoldeMussie; G Ruiz; L A Wheeler; M Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-06       Impact factor: 11.205

Review 6.  The IGF-1 receptor and its contributions to metastatic tumor growth-novel approaches to the inhibition of IGF-1R function.

Authors:  Corinna Bähr; Bernd Groner
Journal:  Growth Factors       Date:  2005-03       Impact factor: 2.511

Review 7.  Markers of beta cell function in type 1 diabetes mellitus.

Authors:  F Vendrame; A Zappaterreno; F Dotta
Journal:  Minerva Med       Date:  2004-04       Impact factor: 4.806

8.  Therapeutic vaccination for closed head injury.

Authors:  Jonathan Kipnis; Uri Nevo; David Panikashvili; Alexander Alexandrovich; Eti Yoles; Solange Akselrod; Esther Shohami; Michal Schwartz
Journal:  J Neurotrauma       Date:  2003-06       Impact factor: 5.269

9.  Vaccination with autoantigen protects against aggregated beta-amyloid and glutamate toxicity by controlling microglia: effect of CD4+CD25+ T cells.

Authors:  Hila Avidan; Jonathan Kipnis; Oleg Butovsky; Rachel R Caspi; Michal Schwartz
Journal:  Eur J Immunol       Date:  2004-12       Impact factor: 5.532

Review 10.  Multiple sclerosis: neuroimmunologic puzzle.

Authors:  B P Barna
Journal:  Clin Lab Med       Date:  1986-03       Impact factor: 1.935

View more
  8 in total

Review 1.  The role of cytokines in Guillain-Barré syndrome.

Authors:  Ming-Ou Lu; Jie Zhu
Journal:  J Neurol       Date:  2010-11-23       Impact factor: 4.849

2.  Endothelin-1 reduces p-glycoprotein transport activity in an in vitro model of human adult blood-brain barrier.

Authors:  Alexandra Hembury; Aloïse Mabondzo
Journal:  Cell Mol Neurobiol       Date:  2008-04-01       Impact factor: 5.046

3.  Caspase-1 causes truncation and aggregation of the Parkinson's disease-associated protein α-synuclein.

Authors:  Wei Wang; Linh T T Nguyen; Christopher Burlak; Fariba Chegini; Feng Guo; Tim Chataway; Shulin Ju; Oriana S Fisher; David W Miller; Debajyoti Datta; Fang Wu; Chun-Xiang Wu; Anuradha Landeru; James A Wells; Mark R Cookson; Matthew B Boxer; Craig J Thomas; Wei Ping Gai; Dagmar Ringe; Gregory A Petsko; Quyen Q Hoang
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-01       Impact factor: 11.205

4.  Coordinated gene expression of Th17- and Treg-associated molecules correlated with resolution of the monophasic experimental autoimmune uveitis.

Authors:  Xiuzhi Jia; Minghui Hu; Caihong Wang; Chunyu Wang; Fengyun Zhang; Qinglian Han; Ruibo Zhao; Qi Huang; Hongwei Xu; Huiping Yuan; Huan Ren
Journal:  Mol Vis       Date:  2011-06-07       Impact factor: 2.367

5.  Anandamide, Acting via CB2 Receptors, Alleviates LPS-Induced Neuroinflammation in Rat Primary Microglial Cultures.

Authors:  Natalia Malek; Katarzyna Popiolek-Barczyk; Joanna Mika; Barbara Przewlocka; Katarzyna Starowicz
Journal:  Neural Plast       Date:  2015-05-18       Impact factor: 3.599

6.  Glycoprotein Pathways Altered in Frontotemporal Dementia With Autoimmune Disease.

Authors:  Fiona Bright; Jared S Katzeff; John R Hodges; Olivier Piguet; Jillian J Kril; Glenda M Halliday; Woojin Scott Kim
Journal:  Front Immunol       Date:  2021-09-01       Impact factor: 7.561

7.  The mTOR kinase inhibitors polarize glioma-activated microglia to express a M1 phenotype.

Authors:  Lucia Lisi; Emilia Laudati; Pierluigi Navarra; Cinzia Dello Russo
Journal:  J Neuroinflammation       Date:  2014-07-23       Impact factor: 8.322

8.  The Synergistic Local Immunosuppressive Effects of Neural Stem Cells Expressing Indoleamine 2,3-Dioxygenase (IDO) in an Experimental Autoimmune Encephalomyelitis (EAE) Animal Model.

Authors:  Young Eun Lee; Jaeyeol An; Kee-Hang Lee; Sung Su Kim; Hye Jin Song; Heejang Pyeon; Hyun Nam; Kyeongjin Kang; Kyeung Min Joo
Journal:  PLoS One       Date:  2015-12-04       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.